Sfoglia per AUTORE
TANI M
Collezione ASL Biella

  

Items : 11

IELSG30 phase 2 trial: intravenous and intrathecal CNS prophylaxis in primary testicular diffuse large B-cell lymphoma. in Blood advances / Blood Adv. 2024 Mar 26;8(6):1541-1549. doi: 10.1182/bloodadvances.2023011251.

2024
ASL Biella
AOU Alessandria
AOU Città della Salute di Torino
AOU Novara

Zucca E; Vitolo U; Pisani F; Pinotti G; Dore F; Esposito F; Pirosa MC; Cesaretti M; Bonomini L; Zanni M; Ghiggi C; Liberati AM; Bruna R; Celli M; Annibali O; Cabras MG; Orsucci L; Tani M; Gaidano G; Balzarotti M; Merli F; Tucci A; Vanazzi A; Sassone M; Botto B; Ferreri AJM; Stathis A; Chiappella A; Conconi A; et alii...

IELSG38: phase II trial of front-line chlorambucil plus subcutaneous rituximab induction and maintenance in mucosa-associated lymphoid tissue lymphoma. in Haematologica / Haematologica. 2024 Aug 1;109(8):2564-2573. doi: 10.3324/haematol.2023.283918.

2024
ASL Biella
AOU Alessandria
AOU Città della Salute di Torino

Stathis A; Pirosa MC; Orsucci L; Feugier P; Tani M; Thieblemont C; Zucca E; Luminari S; Borgo E; Ielmini N; Rossi D; Cavalli F; Bertoni F; Landi F; Spina M; Re F; Pietrantuono G; Houot R; Merli M; Devizzi L; Haioun C; Liberati AM; Celli M; Pulsoni A; Angrilli F; Occhini U; Casasnovas RO; Cartron G; Cabras MG; et alii...

Rituximab and Lenalidomide (R 2) Vs Rituximab Alone As Maintenance Treatment after Chemoimmunotherapy for Elderly Patients with Relapsed/Refractory Follicular Lymphoma (FL): Final Analysis of Renoir Phase III Study of the Fondazione Italiana Linfomi (FIL) in Blood

2023
ASL Biella

Boccomini C; Botto B; Evangelista A; Zilioli VR; Anastasia A; Cavallo F; Merli F; Zanni M; Tani M; Chiarenza A; Liberati AM; Conconi A; Corradini P; Bari A; Annechini G; Gaidano G; Spina M; Sartori R; Castellino C; Puccini B; Arcari A; Bigliardi S; Matta G; Merli M; Mannina D; Marino D; Galieni P; Ciambelli F; Musuraca G; et alii...

17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023 in Hematological oncology

2023
ASL Biella

Thieblemont C; Lamy T; Tani M; Krzisch D; Reda G; Tedeschi A; Usai SV; Guarini A; Bijou F; Stathis A; Anastasia A; Devizzi L; Luminari S; Arcaini L; Casasnovas O; Gressin R; André M; Houot R; Bonomini L; Zucca E; Conconi A;

Treatment of Relapsed/Refractory Waldenström Macroglobulinemia Patients: Final Clinical and Molecular Results of the Phase II Brb (Bendamustine, Rituximab and Bortezomib) Trial of the Fondazione Italiana Linfomi (FIL) in Blood

2021
AOU Città della Salute di Torino
ASL Biella

Benevolo G; Ferrero S; Villivà N; Castiglione A; Monaco F; Boccomini C; Cabras MG; Califano C; Casula P; Cavallo F; Conconi A; Drandi D; Gaidano G; Gregorini AI; Felici S; Ferrante M; Mannina D; Molinari AL; Musto P; Musuraca G; Merli M; Sartori R; Tani M; Varettoni M; Vitolo U; Orsucci L;

Obinutuzumab and miniCHOP for unfit patients with diffuse large B-cell lymphoma. A phase II study by Fondazione Italiana Linfomi. in Journal of geriatric oncology / J Geriatr Oncol. 2020 Jan;11(1):37-40. doi: 10.1016/j.jgo.2019.06.020. Epub 2019 Jul 8.

2020
ASL Biella
AOU Città della Salute di Torino
AOU Novara

Luminari S; Mammi C; Zanni M; Conconi A; Matteucci P; Bari A; Scalone R; Ferrero S; Ferrari A; Molinari AL; Liberati AM; Tani M; Gini G; Merli M; Nassi L; Tucci A; Salvi F; Musuraca G; Cavallo F; Merli F;

Outcome of diffuse large B-cell lymphoma associated with hepatitis c virus in elderly patients: Results of the prospective “elderly project” by the fondazione italiana linfomi (FIL) in HemaSphere

2020
ASL Biella
ASL Asti
AO Ordine Mauriziano
AOU Città della Salute di Torino
AOU San Luigi di Orbassano

Mammi C; Luminari S; Marcheselli L; Marino D; Arcaini L; Tarantini G; Pozzi S; Di Rocco A; Re F; Flenghi L; Sartori R; Cabras MG; Tani M; Puccini B; Ladetto M; Chiappella A; Nassi L; Vallisa D; Angrilli F; Arcari A; Gini G; Zilioli VR; Spina M; Merli M; Balzarotti M; Fabbri A; Cavallo F; Ghentile M; Merli F; et alii...

Lenalidomide in Pretreated Patients with Diffuse Large B-Cell Lymphoma: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice. in The oncologist / Oncologist. 2019 Sep;24(9):1246-1252. doi: 10.1634/theoncologist.2018-0603. Epub 2019 Apr 2.

2019
ASL Biella
AO Cuneo
AOU Città della Salute di Torino

Zinzani PL; Castellino C; Gaudio F; Argnani L; Zancanella M; Paolini R; Rigacci L; Devizzi L; Monaco F; Romano A; Fama A; Patti C; Musuraca G; Tecchio C; Marino D; Goldaniga MC; Marasca R; Cox MC; Cascavilla N; Conconi A; Balzarotti M; Tani M; Broccoli A; Casadei B; Chiappella A; Visco C;

The role of central nervous system prophylaxis and contralateral testis radiotherapy in primary testicular lymphoma: Long term analysis of the phase II IELSG10 study and preliminary results of the IELSG30 study of international extranodal lymphoma study group and fondazione Italiana linfomi in Haematologica

2019
ASL Biella

Chiappella A; Zucca E; Ferreri AJM; Ciccone G; Vanazzi A; Martelli M; Tucci A; Balzarotti M; Merli F; Cabras MG; Nassi L; Pavone V; Storti S; Tani M; Molinari AL; Conconi A; Gomez H; Lopez-Guillermo A; Sarris AH; Ricardi U; Gospodarowicz MK; Cavalli F; Vitolo U;

Clinical and molecular results of the phase II BRB (bendamustine, rituximab and bortezomib) trial of the fondazione italiana linfomi (FIL) for relapsed/refractory waldenström macroglobulinemia patients in Blood

2018
ASL Biella
AOU Città della Salute di Torino

Benevolo G; Ferrero S; Andriani A; Castiglione A; Baraldi A; Boccomini C; Cabras MG; Califano C; Cavallo F; Conconi A; Curreli L; Drandi D; Gaidano G; Felici S; Ferrante M; Mannina D; Merli M; Molinari AL; Musto P; Musuraca G; Rossi FG; Sartori R; Tani M; Varettoni M; Vitolo U; Orsucci L;

IELSG-38: A phase II study of chlorambucil in combination with rituximab followed by maintenance therapy with subcutaneous rituximab in patients with extranodal marginal zone B-cell lymphoma of mucosa associated lymphoid tissue (MALT) in Blood

2017
ASL Biella

Luminari S; Cavalli F; Zucca E; Thieblemont C; Molinari AL; Pulsoni A; Ielmini N; Cabras MG; Capochiani E; Califano C; Tilly H; Salvi F; Conconi A; Palombi F; Cavallo F; Gouill SL; Gini G; Ferrari A; Gyan E; Morschhauser F; Coiffier B; Musuraca G; Guieze R; Marino D; Stathis A; Gregorini A; Gressin R; Orsucci L; Perrot A; et alii...